Targeting of circulating hepatocellular carcinoma cells to prevent postoperative recurrence and metastasis
about
The suppressive effect of resveratrol on HIF-1α and VEGF expression after warm ischemia and reperfusion in rat liverOblongifolin C inhibits metastasis by up-regulating keratin 18 and tubulinsMidkine promotes hepatocellular carcinoma metastasis by elevating anoikis resistance of circulating tumor cells.Improved method increases sensitivity for circulating hepatocellular carcinoma cells.Expression of cancer stem cell biomarkers as a tool for a correct therapeutic approach to hepatocellular carcinoma.Phosphorylated Heat Shock Protein 20 (HSPB6) Regulates Transforming Growth Factor-α-Induced Migration and Invasion of Hepatocellular Carcinoma Cells.Gemcitabine and Antisense-microRNA Co-encapsulated PLGA-PEG Polymer Nanoparticles for Hepatocellular Carcinoma Therapy.Androgen receptor mitigates postoperative disease progression of hepatocellular carcinoma by suppressing CD90+ populations and cell migration and by promoting anoikis in circulating tumor cells.Prognosis of Hepatocellular Carcinoma after Liver Transplantation: Comparative Analysis with Partial Hepatectomy.Potential role of miR-100 in cancer diagnosis, prognosis, and therapy.Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility.Treating ischaemia-reperfusion injury with prostaglandin E1 reduces the risk of early hepatocellular carcinoma recurrence following liver transplantation.Liver transplantation for hepatocellular carcinoma - factors influencing outcome and disease-free survival.Donor interleukin 6 gene polymorphisms predict the recurrence of hepatocellular carcinoma after liver transplantation.Postoperative peak serum C-reactive protein is a predictor of outcome following liver transplantation for hepatocellular carcinoma.Microfluidic chip for isolation of viable circulating tumor cells of hepatocellular carcinoma for their culture and drug sensitivity assay.Pooling-analysis for diagnostic and prognostic value of MiRNA-100 in various cancers.Silencing of survivin by YM155 induces apoptosis and growth arrest in hepatocellular carcinoma cells.Characteristic proteins in the plasma of postoperative colorectal and liver cancer patients with Yin deficiency of liver-kidney syndrome.Effects of cyclin D1 gene silencing on cell proliferation, cell cycle, and apoptosis of hepatocellular carcinoma cells.Correlation Between Postoperative Early Recurrence of Hepatocellular Carcinoma and Mesenchymal Circulating Tumor Cells in Peripheral Blood.Application of a novel liquid biopsy in patients with hepatocellular carcinoma undergoing liver transplantation.Extended Ischemia Times Promote Risk of HCC Recurrence in Liver Transplant Patients.
P2860
Q28543622-BEB1DC2D-C165-484E-8429-80E3E412A5EDQ30650458-6BB7ABF1-A132-43E7-9158-9599998707A0Q33779147-CCEE53F2-224E-483A-9F20-747704CFEE75Q35169325-BC59CA34-41E6-43B3-AFD9-5ABC09000566Q35745018-6B9608A3-A80D-4F69-AA42-58D06821AB99Q35979922-744B8D13-ABA4-4A14-A64C-8191DE5BB5DFQ37550964-8C6C146B-5345-40F0-95A1-792AD09B706FQ37564767-C5BD77C1-9A1F-4425-BDF4-5E2D3CBD844FQ37615300-DB3C0E86-3924-4EB6-BACA-EDB2406DC604Q38367693-0F2C429A-3D60-43A7-958D-DF849F7584ADQ38450711-6E8BAA05-4023-45BD-9DDB-5E2B67FFAAD3Q38568533-4F3F3E9F-90EE-4B06-97D2-8624A87B15EAQ38635611-75B94485-D8AF-4B1C-859A-E42D8949819BQ39638633-8AE71238-3802-4564-BD72-62513D468717Q40235716-DC7E80EA-D5B0-4B43-AE6D-B96F02515B38Q41697309-42772010-B163-4219-9830-C472CC7F8BB0Q42365364-4D62035C-BAAB-44CB-A84D-ADD45F8B9170Q42457038-6D1FFBAD-0378-4E55-8263-BAE8E7F73575Q47147755-188C312D-6C6A-4DB6-BA87-64C64A12FEDBQ48103601-3CAA948E-CCB1-4868-A749-CF402C35AC11Q49843525-6E44A727-FDD6-4C1F-8A39-E273F5E35DB6Q52649698-43E0A7CD-E114-437A-B1DB-7A3C0EADBFA1Q53028734-7DCEB5B9-E2BF-4767-A6BB-1DD994D15F31
P2860
Targeting of circulating hepatocellular carcinoma cells to prevent postoperative recurrence and metastasis
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting of circulating hepat ...... tive recurrence and metastasis
@en
Targeting of circulating hepat ...... ive recurrence and metastasis.
@nl
type
label
Targeting of circulating hepat ...... tive recurrence and metastasis
@en
Targeting of circulating hepat ...... ive recurrence and metastasis.
@nl
prefLabel
Targeting of circulating hepat ...... tive recurrence and metastasis
@en
Targeting of circulating hepat ...... ive recurrence and metastasis.
@nl
P2093
P2860
P356
P1476
Targeting of circulating hepat ...... tive recurrence and metastasis
@en
P2093
Zheng-Feng Yin
Zhi-Long Shi
P2860
P304
P356
10.3748/WJG.V20.I1.142
P407
P577
2014-01-01T00:00:00Z